Analyst Ratings for Zenas Biopharma (ZBIO)
ZBIO Rating Summary
ZBIO Price Target Summary
- Highest: $55.00 (Guggenheim)
- Lowest: $22.00 (Morgan Stanley)
- Average: $42.00
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$42.00 (+112.3%)
* Over Last 12-Mos
Rating Score: 8.8 / 10
Percentile Rank: 88%
Avg. $ Target:
$42.00 (+112.3%)
* Over Last 12-Mos
Rating Score: 8.8 / 10
Percentile Rank: 88%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 1/5/2026 | Morgan Stanley » Updated 5/14/2026 |
Judah C. Frommer | Downgrade | Equalweight (Overweight) |
22.00 (21.00) |
34.50 (19.78) |
-42.67% | Details |
| 3/20/2025 | Wedbush | Martin Fan | New Coverage | Outperform (N/A) |
35.00 (N/A) |
8.25 (19.78) |
139.76% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
